{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:43:43Z","timestamp":1792176223648,"version":"4.4.0"},"reference-count":54,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Swiss National Science Foundation","award":["310030_192613"],"award-info":[{"award-number":["310030_192613"]}],"id":[{"id":"https:\/\/ror.org\/00yjd3n13","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Swiss National Science Foundation (SNSF}","award":["310030_188803"],"award-info":[{"award-number":["310030_188803"]}],"id":[{"id":"https:\/\/ror.org\/00yjd3n13","id-type":"ROR","asserted-by":"crossref"}]},{"name":"European Research Council","award":["268721 \u2014 KRABnKAP"],"award-info":[{"award-number":["268721 \u2014 KRABnKAP"]}],"id":[{"id":"https:\/\/ror.org\/0472cxd90","id-type":"ROR","asserted-by":"crossref"}]},{"name":"European Research Council","award":["694658 \u2014 Transpos-X"],"award-info":[{"award-number":["694658 \u2014 Transpos-X"]}],"id":[{"id":"https:\/\/ror.org\/0472cxd90","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Personalized Health and Related Technologies (PHRT) \/ Swiss Data Science Center (SDSC), 1st Joint SDSC Call for Data-Intensive Research","id":[{"id":"https:\/\/ror.org\/02hdt9m26","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Swiss Personalized Health Network (SPHN), Swiss Academy of Medical Sciences initiative","award":["2017-407"],"award-info":[{"award-number":["2017-407"]}],"id":[{"id":"https:\/\/ror.org\/011cav305","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Swiss Cancer League","id":[{"id":"https:\/\/ror.org\/01pd7my79","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Aclon Foundation"}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"abstract":"<jats:p>\n                    Analyses routinely conducted in both fundamental research and biomedical studies often report aggregate signals derived from heterogeneous mixtures of cells. These mixtures reflect the intrinsic anatomical and functional complexity of the tissues and organs from which they are derived. Such bulk measurements obscure cell-specific signals, thereby hindering accurate interpretation of the underlying biological processes. Here, we introduce CLIMB and CLIFF, a two-step machine-learning framework that deconvolves bulk RNA-seq into cell-type composition and expression, and then resolves bulk drug sensitivity measurements into cell subtype- and single-cell-specific profiles. We first validate CLIMB using in-vitro mixtures of leukemic cell lines with experimentally known cell-type proportions, then extend this validation to large-scale, cross-dataset pseudo-bulk analyses built from independent scRNA-seq references across two disease contexts and five cancer types \u2014 mimicking the reference-to-target mismatches encountered in real applications \u2014 and show that CLIMB accurately infers the cellular composition of bulk samples, outperforming state-of-the-art bulk deconvolution methods. We emphasize CLIMB\u2019s effectiveness in acute myeloid leukemia, where it offers highly accurate estimation of leukemic stem cell fractions across three test datasets and three patient cohorts. We then validate CLIFF, our algorithm for estimating cell subtype- and single-cell-specific drug sensitivity, first on the same in-vitro cell line mixtures using experimentally measured drug responses, and then through in-depth, realistic-scale pseudo-bulk simulations. We applied our deconvolution strategy to the beatAML cohort dataset, currently the most extensive database of\n                    <jats:italic>ex-vivo<\/jats:italic>\n                    drug screening data. This analysis generated a cell subtype\u2013resolved drug sensitivity landscape for 121 compounds, revealing multiple compounds putatively active against leukemic stem cells, including midostaurin, A-674563, SNS-032, and foretinib. Collectively, our work introduces a general computational framework for resolving bulk functional measurements at cell-type and single-cell resolution, providing an attractive new computational tool for drug development and precision medicine.\n                  <\/jats:p>","DOI":"10.1371\/journal.pcbi.1014862","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:43:57Z","timestamp":1792172637000},"page":"e1014862","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Computational deconvolution of drug sensitivity via single-cell\u2013to\u2013bulk transcriptome mapping"],"prefix":"10.1371","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4584-4410","authenticated-orcid":true,"given":"Alexandre","family":"Coudray","sequence":"first","affiliation":[{"name":"EPFL - Ecole Polytechnique F\u00e9d\u00e9rale de Lausanne","place":["Ecublens, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Forey","sequence":"additional","affiliation":[{"name":"EPFL - Ecole Polytechnique F\u00e9d\u00e9rale de Lausanne","place":["Ecublens, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Bejar Haro","sequence":"additional","affiliation":[{"name":"SDSC - Swiss Data Science Center","place":["Ecublens, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filipe","family":"Martins","sequence":"additional","affiliation":[{"name":"EPFL - Ecole Polytechnique F\u00e9d\u00e9rale de Lausanne","place":["Ecublens, Switzerland"]},{"name":"Centre Hospitalier Universitaire Vaudois (CHUV), Hematology Service and Central laboratory","place":["Lausanne, Switzerland"],"department":["Oncology department"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Carlevaro-Fita","sequence":"additional","affiliation":[{"name":"EPFL - Ecole Polytechnique F\u00e9d\u00e9rale de Lausanne","place":["Ecublens, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoline","family":"Sheppard","sequence":"additional","affiliation":[{"name":"EPFL - Ecole Polytechnique F\u00e9d\u00e9rale de Lausanne","place":["Ecublens, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra Eloise","family":"Offner","sequence":"additional","affiliation":[{"name":"EPFL - Ecole Polytechnique F\u00e9d\u00e9rale de Lausanne","place":["Ecublens, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gioele","family":"La Manno","sequence":"additional","affiliation":[{"name":"EPFL - Ecole Polytechnique F\u00e9d\u00e9rale de Lausanne","place":["Ecublens, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Obozinski","sequence":"additional","affiliation":[{"name":"EPFL - Ecole Polytechnique F\u00e9d\u00e9rale de Lausanne","place":["Ecublens, Switzerland"]},{"name":"SDSC - Swiss Data Science Center","place":["Ecublens, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Trono","sequence":"additional","affiliation":[{"name":"EPFL - Ecole Polytechnique F\u00e9d\u00e9rale de Lausanne","place":["Ecublens, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,10,16]]},"reference":[{"issue":"1","key":"pcbi.1014862.ref001","doi-asserted-by":"crossref","first-page":"101290","DOI":"10.1016\/j.tranon.2021.101290","article-title":"High-throughput ex vivo drug testing identifies potential drugs and drug combinations for NRAS-positive malignant melanoma","volume":"15","author":"L Kohtam\u00e4ki","year":"2022","journal-title":"Transl Oncol"},{"issue":"1","key":"pcbi.1014862.ref002","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41408-020-0276-7","article-title":"Application of an ex-vivo drug sensitivity platform towards achieving complete remission in a refractory T-cell lymphoma","volume":"10","author":"S de Mel","year":"2020","journal-title":"Blood Cancer J"},{"issue":"12","key":"pcbi.1014862.ref003","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1182\/bloodadvances.2020001934","article-title":"Ex vivo drug screening defines novel drug sensitivity patterns for informing personalized therapy in myeloid neoplasms","volume":"4","author":"MA Spinner","year":"2020","journal-title":"Blood Adv"},{"key":"pcbi.1014862.ref004","first-page":"116","article-title":"Single Cell Isolation and Analysis","volume":"4","author":"P Hu","year":"2016","journal-title":"Front Cell Dev Biol"},{"issue":"4","key":"pcbi.1014862.ref005","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s43018-022-00356-3","article-title":"Cell type and gene expression deconvolution with BayesPrism enables Bayesian integrative analysis across bulk and single-cell RNA sequencing in oncology","volume":"3","author":"T Chu","year":"2022","journal-title":"Nat Cancer"},{"issue":"7","key":"pcbi.1014862.ref006","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","article-title":"Determining cell type abundance and expression from bulk tissues with digital cytometry","volume":"37","author":"AM Newman","year":"2019","journal-title":"Nat Biotechnol"},{"issue":"1","key":"pcbi.1014862.ref007","doi-asserted-by":"crossref","first-page":"6735","DOI":"10.1038\/s41467-022-34550-9","article-title":"Deep autoencoder for interpretable tissue-adaptive deconvolution and cell-type-specific gene analysis","volume":"13","author":"Y Chen","year":"2022","journal-title":"Nat Commun"},{"issue":"30","key":"pcbi.1014862.ref008","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba2619","article-title":"Deep learning-based cell composition analysis from tissue expression profiles","volume":"6","author":"K Menden","year":"2020","journal-title":"Sci Adv"},{"issue":"1","key":"pcbi.1014862.ref009","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/s41467-018-08023-x","article-title":"Bulk tissue cell type deconvolution with multi-subject single-cell expression reference","volume":"10","author":"X Wang","year":"2019","journal-title":"Nat Commun"},{"issue":"10","key":"pcbi.1014862.ref010","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/ng.2764","article-title":"The Cancer Genome Atlas Pan-Cancer analysis project","volume":"45","author":"Network Cancer Genome Atlas Research","year":"2013","journal-title":"Nat Genet"},{"issue":"23","key":"pcbi.1014862.ref011","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","article-title":"Genomic Classification and Prognosis in Acute Myeloid Leukemia","volume":"374","author":"E Papaemmanuil","year":"2016","journal-title":"N Engl J Med"},{"issue":"7728","key":"pcbi.1014862.ref012","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41586-018-0623-z","article-title":"Functional genomic landscape of acute myeloid leukaemia","volume":"562","author":"JW Tyner","year":"2018","journal-title":"Nature"},{"issue":"15","key":"pcbi.1014862.ref013","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1182\/blood.2022019166","article-title":"Analysis and therapeutic targeting of the IL-1R pathway in anaplastic large cell lymphoma","volume":"142","author":"Z Song","year":"2023","journal-title":"Blood"},{"issue":"5","key":"pcbi.1014862.ref014","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1158\/2643-3230.BCD-21-0012","article-title":"Monocytic differentiation and AHR signaling as Primary Nodes of BET Inhibitor Response in Acute Myeloid Leukemia","volume":"2","author":"KA Romine","year":"2021","journal-title":"Blood Cancer Discov"},{"issue":"10","key":"pcbi.1014862.ref015","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1182\/bloodadvances.2021006307","article-title":"Associating drug sensitivity with differentiation status identifies effective combinations for acute myeloid leukemia","volume":"6","author":"SE Kurtz","year":"2022","journal-title":"Blood Adv"},{"issue":"3","key":"pcbi.1014862.ref016","doi-asserted-by":"crossref","first-page":"708","DOI":"10.3324\/haematol.2018.214882","article-title":"Phenotype-based drug screening reveals association between venetoclax response and differentiation stage in acute myeloid leukemia","volume":"105","author":"H Kuusanm\u00e4ki","year":"2020","journal-title":"Haematologica"},{"issue":"4","key":"pcbi.1014862.ref017","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1158\/2159-8290.CD-19-0710","article-title":"Monocytic Subclones Confer Resistance to Venetoclax-Based Therapy in Patients with Acute Myeloid Leukemia","volume":"10","author":"S Pei","year":"2020","journal-title":"Cancer Discov"},{"issue":"8","key":"pcbi.1014862.ref018","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/s43018-020-0103-x","article-title":"Integrated analysis of patient samples identifies biomarkers for venetoclax efficacy and combination strategies in acute myeloid leukemia","volume":"1","author":"H Zhang","year":"2020","journal-title":"Nat Cancer"},{"issue":"1","key":"pcbi.1014862.ref019","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41698-021-00209-9","article-title":"Bayesian multi-source regression and monocyte-associated gene expression predict BCL-2 inhibitor resistance in acute myeloid leukemia","volume":"5","author":"BS White","year":"2021","journal-title":"NPJ Precis Oncol"},{"issue":"21","key":"pcbi.1014862.ref020","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.4161\/cc.22382","article-title":"Erlotinib antagonizes ABC transporters in acute myeloid leukemia","volume":"11","author":"E Lainey","year":"2012","journal-title":"Cell Cycle"},{"issue":"4","key":"pcbi.1014862.ref021","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.bbrc.2016.02.094","article-title":"Concurrent targeting Akt and sphingosine kinase 1 by A-674563 in acute myeloid leukemia cells","volume":"472","author":"L Xu","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"issue":"18","key":"pcbi.1014862.ref022","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1182\/blood-2013-05-505735","article-title":"Role of altered growth factor receptor-mediated JAK2 signaling in growth and maintenance of human acute myeloid leukemia stem cells","volume":"123","author":"AM Cook","year":"2014","journal-title":"Blood"},{"issue":"1","key":"pcbi.1014862.ref023","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054826","article-title":"mTOR inhibitors alone and in combination with JAK2 inhibitors effectively inhibit cells of myeloproliferative neoplasms","volume":"8","author":"C Bogani","year":"2013","journal-title":"PLoS One"},{"issue":"65","key":"pcbi.1014862.ref024","doi-asserted-by":"crossref","first-page":"108738","DOI":"10.18632\/oncotarget.21877","article-title":"Azacitidine combined with the selective FLT3 kinase inhibitor crenolanib disrupts stromal protection and inhibits expansion of residual leukemia-initiating cells in FLT3-ITD AML with concurrent epigenetic mutations","volume":"8","author":"A-K Garz","year":"2017","journal-title":"Oncotarget"},{"key":"pcbi.1014862.ref025","doi-asserted-by":"crossref","first-page":"112962","DOI":"10.1016\/j.biopha.2022.112962","article-title":"ABCB1 as a potential beneficial target of midostaurin in acute myeloid leukemia","volume":"150","author":"S Sucha","year":"2022","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"pcbi.1014862.ref026","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/leu.2015.194","article-title":"Activity of a selective inhibitor of nuclear export, selinexor (KPT-330), against AML-initiating cells engrafted into immunosuppressed NSG mice","volume":"30","author":"J Etchin","year":"2016","journal-title":"Leukemia"},{"issue":"9","key":"pcbi.1014862.ref027","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1038\/leu.2008.144","article-title":"PI-103, a dual inhibitor of Class IA phosphatidylinositide 3-kinase and mTOR, has antileukemic activity in AML","volume":"22","author":"S Park","year":"2008","journal-title":"Leukemia"},{"issue":"6","key":"pcbi.1014862.ref028","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2019.01.031","article-title":"Single-Cell RNA-Seq Reveals AML Hierarchies Relevant to Disease Progression and Immunity","volume":"176","author":"P van Galen","year":"2019","journal-title":"Cell"},{"issue":"10","key":"pcbi.1014862.ref029","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1038\/s41375-021-01338-7","article-title":"Single cell RNA sequencing of AML initiating cells reveals RNA-based evolution during disease progression","volume":"35","author":"LC Stetson","year":"2021","journal-title":"Leukemia"},{"issue":"3","key":"pcbi.1014862.ref030","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41568-019-0230-9","article-title":"The leukaemia stem cell: similarities, differences and clinical prospects in CML and AML","volume":"20","author":"D Vetrie","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"pcbi.1014862.ref031","doi-asserted-by":"crossref","first-page":"102993","DOI":"10.1016\/j.critrevonc.2020.102993","article-title":"Targeting acute myeloid leukemia stem cells: Current therapies in development and potential strategies with new dimensions","volume":"152","author":"Y Tan","year":"2020","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"pcbi.1014862.ref032","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1038\/s41467-021-21650-1","article-title":"Identification of leukemic and pre-leukemic stem cells by clonal tracking from single-cell transcriptomics","volume":"12","author":"L Velten","year":"2021","journal-title":"Nat Commun"},{"issue":"3","key":"pcbi.1014862.ref033","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/s41375-019-0604-8","article-title":"A six-gene leukemic stem cell score identifies high risk pediatric acute myeloid leukemia","volume":"34","author":"AH Elsayed","year":"2020","journal-title":"Leukemia"},{"issue":"24","key":"pcbi.1014862.ref034","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1001\/jama.2010.1862","article-title":"Association of a leukemic stem cell gene expression signature with clinical outcomes in acute myeloid leukemia","volume":"304","author":"AJ Gentles","year":"2010","journal-title":"JAMA"},{"issue":"7633","key":"pcbi.1014862.ref035","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/nature20598","article-title":"A 17-gene stemness score for rapid determination of risk in acute leukaemia","volume":"540","author":"SWK Ng","year":"2016","journal-title":"Nature"},{"issue":"1","key":"pcbi.1014862.ref036","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1038\/s41467-020-15816-6","article-title":"Accurate estimation of cell composition in bulk expression through robust integration of single-cell information","volume":"11","author":"B Jew","year":"2020","journal-title":"Nat Commun"},{"issue":"1","key":"pcbi.1014862.ref037","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/s41467-023-36969-0","article-title":"Longitudinal single-cell profiling of chemotherapy response in acute myeloid leukemia","volume":"14","author":"MM Naldini","year":"2023","journal-title":"Nat Commun"},{"issue":"6","key":"pcbi.1014862.ref038","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s41588-020-0636-z","article-title":"Lineage-dependent gene expression programs influence the immune landscape of colorectal cancer","volume":"52","author":"H-O Lee","year":"2020","journal-title":"Nat Genet"},{"issue":"1","key":"pcbi.1014862.ref039","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13059-022-02677-z","article-title":"Refining colorectal cancer classification and clinical stratification through a single-cell atlas","volume":"23","author":"AM Khaliq","year":"2022","journal-title":"Genome Biol"},{"issue":"11","key":"pcbi.1014862.ref040","article-title":"A human breast atlas integrating single-cell proteomics and transcriptomics","volume":"57","author":"GK Gray","year":"2022","journal-title":"Dev Cell"},{"issue":"9","key":"pcbi.1014862.ref041","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1038\/s41588-021-00911-1","article-title":"A single-cell and spatially resolved atlas of human breast cancers","volume":"53","author":"SZ Wu","year":"2021","journal-title":"Nat Genet"},{"issue":"4","key":"pcbi.1014862.ref042","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2019.06.024","article-title":"An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma","volume":"178","author":"C Neftel","year":"2019","journal-title":"Cell"},{"issue":"4","key":"pcbi.1014862.ref043","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2018.09.006","article-title":"A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade","volume":"175","author":"L Jerby-Arnon","year":"2018","journal-title":"Cell"},{"issue":"6282","key":"pcbi.1014862.ref044","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1126\/science.aad0501","article-title":"Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq","volume":"352","author":"I Tirosh","year":"2016","journal-title":"Science"},{"key":"pcbi.1014862.ref045","doi-asserted-by":"crossref","unstructured":"Ziegler CGK, Miao VN, Owings AH, Navia AW, Tang Y, Bromley JD, et al. Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19. Cell. 2021.","DOI":"10.1101\/2021.02.20.431155"},{"key":"pcbi.1014862.ref046","unstructured":"Leucegene. https:\/\/dataleucegeneiricca\/"},{"issue":"22","key":"pcbi.1014862.ref047","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","article-title":"Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia","volume":"368","author":"Network Cancer Genome Atlas Research","year":"2013","journal-title":"N Engl J Med"},{"issue":"4","key":"pcbi.1014862.ref048","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2141.1976.tb03563.x","article-title":"Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group","volume":"33","author":"JM Bennett","year":"1976","journal-title":"Br J Haematol"},{"issue":"6","key":"pcbi.1014862.ref049","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/s41591-022-01819-x","article-title":"A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemia","volume":"28","author":"AGX Zeng","year":"2022","journal-title":"Nat Med"},{"issue":"8","key":"pcbi.1014862.ref050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2022.07.002","article-title":"Integrative analysis of drug response and clinical outcome in acute myeloid leukemia","volume":"40","author":"D Bottomly","year":"2022","journal-title":"Cancer Cell"},{"key":"pcbi.1014862.ref051","doi-asserted-by":"crossref","unstructured":"Karakaslar EO, Severens J, S\u00e1nchez-L\u00f3pez E, van Veelen PA, Zlei M, van Dongen JJ. Single cell guided deconvolution of bulk transcriptomics recapitulates differentiation stages of acute myeloid leukemia and predicts drug response. Bioarxiv. 2022.","DOI":"10.1101\/2022.12.09.519738"},{"issue":"1","key":"pcbi.1014862.ref052","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13059-020-02048-6","article-title":"Systematic assessment of tissue dissociation and storage biases in single-cell and single-nucleus RNA-seq workflows","volume":"21","author":"E Denisenko","year":"2020","journal-title":"Genome Biol"},{"issue":"10","key":"pcbi.1014862.ref053","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/nmeth.4437","article-title":"Single-cell sequencing reveals dissociation-induced gene expression in tissue subpopulations","volume":"14","author":"SC van den Brink","year":"2017","journal-title":"Nat Methods"},{"issue":"1","key":"pcbi.1014862.ref054","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v033.i01","article-title":"Regularization Paths for Generalized Linear Models via Coordinate Descent","volume":"33","author":"J Friedman","year":"2010","journal-title":"J Stat Softw"}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1014862","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:44:09Z","timestamp":1792172649000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1014862"}},"subtitle":[],"editor":[{"given":"Zhaoyuan","family":"Fang","sequence":"first","affiliation":[{"name":"Zhejiang University","place":["CHINA"]}],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,10,16]]},"references-count":54,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1014862","relation":{},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,16]]}}}